| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Maze Therapeutics, Inc. (MAZE) has 16 insiders with recent SEC Form 4 filings, including 0 buys and 3 sells. MAZE is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 4.47M | $124.42M | - | |
| CFO | 325.0K | $9.04M | - | |
| CEO | 100.0K | $2.78M | - | |
| Dir | 36.0K | $1.00M | - | |
| Dir | 31.1K | $865.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 29, 2025 | Bernstein Harold64 | President, R&D &CMO | Sale+OE | 45,000 | $40.56 | $1,825,354.84 | -72.3% | -28.5% | - | |
| Sep 15, 2025 | Scheller Richard H90 | Director | Sell | 20,744 | $22.37 | $464,034.98 | -100% | +70.8% | - |